Market Place
Sourcing Support
All News #Library
Others
ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus
25 Oct 2025 //
GLOBENEWSWIRE
ITM Appoints Annette Breunig As Chief People Officer
13 Oct 2025 //
GLOBENEWSWIRE
ITM Presents Ph3 COMPETE Data On 177Lu-edotreotide In GEP-NETs
08 Oct 2025 //
GLOBENEWSWIRE
ITM and ILL Extend Collaboration on Medical Lutetium-177 Supply
16 Jun 2025 //
GLOBENEWSWIRE
ITM Secures $262.5m Debt Financing with Blue Owl Managed Funds
27 May 2025 //
GLOBENEWSWIRE
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
01 Apr 2025 //
GLOBENEWSWIRE
ITM Announces Updates to Commercial Leadership
13 Mar 2025 //
GLOBENEWSWIRE
ITM To Present Ph 3 COMPETE Trial Data On GEP-NETs At ENETS
25 Feb 2025 //
GLOBENEWSWIRE
ITM to Present at Oppenheimer’s 35th Annual Healthcare Conference
07 Feb 2025 //
GLOBENEWSWIRE
ITM P 3 Compete Trial Shows Positive ITM-11 Data In GEP-NETs Tumors
28 Jan 2025 //
GLOBENEWSWIRE
ITM to Participate in Upcoming Investor Conferences
11 Nov 2024 //
GLOBENEWSWIRE
ITM Raises €188M For Radiopharma Pipeline, Radioisotope Manufacturing
06 Jun 2024 //
GLOBENEWSWIRE
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
07 May 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.